Altair Nanotechnologies Expands Intellectual Property Portfolio With New U.S. Patent Issue
21 December 2005
Altair Nanotechnologies, Inc. (NASDAQ: ALTI) today
announced that the U.S. Patent Office issued Altair U.S. Patent 6,974,566 a
'Method For Producing Mixed Metal Oxides and Metal Oxide Compounds.' The
patent describes the process and underlying technology for the manufacture
of mixed metal oxides and metal oxide compounds from aqueous solutions.
The patent extends Altairnano's platform technology and expands
Altairnano's intellectual property for manufacture of metal oxide
nano-structured materials. The process is currently used to manufacture
the following Altairnano products:
-- Titanium dioxide pigment, as embodied in Altairnano's proprietary
Hydrochloride Pigment process (AHP).
-- Nano-sized titanium dioxide used as photo-catalytic materials to
remove air born contaminates like smoke or food odors and for self-cleaning
surfaces.
-- Nano-structured lithium titanate spinel electrode materials used in
high power lithium ion batteries.
-- Stabilized Zirconia materials for use as nano-sized, spray-grade
powers for thermal coatings and for nano-structured dental products.
-- Aluminum-Titanium and yttrium oxide used in nano-sized thermal spray
grade powders.
Altairnano continues to expend significant resources to pioneer, develop
and protect advanced ceramic nanotechnology used in numerous product
applications.
ALTAIR NANOTECHNOLOGIES, INC.
Altairnano is a leading supplier and innovator of advanced ceramic
nanomaterial technology. Based in Reno, Nevada, Altairnano has assembled a
unique team of materials scientists who, coupled in collaborative ventures
with industry partners and leading academic centers, have pioneered an
array of intellectual property and products.
Altairnano's robust proprietary technology platforms produce a variety of
crystalline and non-crystalline nanomaterials of unique structure,
performance, quality and cost. The company has scalable manufacturing
capability to meet emerging nanomaterials demands. Altairnano's two
divisions, Life Sciences and Performance Materials, are focused on
applications where its nanotechnology may enable new high growth markets.
The Life Sciences Division is pursuing market applications in
pharmaceuticals, drug delivery, dental materials and other medical markets.
The Performance Materials Division is focused on market applications in
advanced materials for paints and coatings; air and water treatment and
alternative energy including new lithium ion battery electrode materials.
For additional information on Altairnano and its nanomaterials, visit
www.altairnano.com
Forward-Looking Statements
This release may contain forward-looking statements as well as historical
information. Forward-looking statements, which are included in accordance
with the "safe harbor" provisions of the Private Securities Litigation
Reform Act of 1995, may involve risks, uncertainties and other factors that
may cause the company's actual results and performance in future periods to
be materially different from any future results or performance suggested by
the forward-looking statements in this release. These risks and
uncertainties include, without limitation, the risks that any patents
granted to Altairnano may be invalidated or circumvented, that competitors
may develop alternative processes that are similar or superior to those
patented by Altairnano, that the products referenced in this release (or
end products incorporating such products) will not be developed to the
point of commercialization, that, even if commercialized, no market will
exist for such products or that Altair or its partners will fail to
effectively market to end products produced using Altairnano's proprietary
processes. In addition, other risks are identified in the company's most
recent Annual Report on Form 10-K, as filed with the SEC. Such
forward-looking statements speak only as of the date of this release. The
company expressly disclaims any obligation to update or revise any
forward-looking statements found herein to reflect any changes in company
expectations or results or any change in events.
Investor and Financial Relations:
Marty Tullio or Mark D. Tullio
McCloud Communications, LLC
949.553.9748
Email Contact
Email Contact
Company Contact:
Robert Pedraza
VP Strategy & Business Development
Altair Nanotechnologies, Inc.
775.856.2500
Email Contact
SOURCE: Altair Nanotechnologies, Inc.
Source: marketwire
All trademarks and copyrighted information contained herein are the property of their respective owners.
Related Articles
|
